Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 5/20 | 0.43 |
| ▸ | NMT2 | O60551 | 4/20 | 0.43 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 3/20 | 0.39 |
| ▸ | MMP3 | P08254 | 3/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.36 |
| ▸ | FURIN | P09958 | 1/20 | 0.36 |
| ▸ | Q9HBH1 | 1/20 | 0.35 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24453587 | 0.89 | NMT2 (0.37) | NMT1NMT2SIRT6SIRT1MMP1 | |
| SCHEMBL23682447 | 0.89 | NMT2 (0.37) | NMT1NMT2SIRT6SIRT1MMP1 | |
| SCHEMBL24090073 | 0.88 | NMT1 (0.38) | NMT1NMT2SIRT6SIRT1MMP1 | |
| SCHEMBL14961163 | 0.84 | SIRT6 (0.43) | NMT1NMT2SIRT6SIRT1FOLH1 | |
| SCHEMBL14961162 | 0.84 | SIRT6 (0.43) | NMT1NMT2SIRT6SIRT1FOLH1 | |
| SCHEMBL15905676 | 0.84 | SIRT6 (0.42) | NMT1NMT2SIRT6SIRT1MMP1 | |
| SCHEMBL23758316 | 0.84 | SIRT6 (0.42) | NMT1NMT2SIRT6SIRT1MMP1 | |
| SCHEMBL24765399 | 0.83 | FOLH1 (0.54) | NMT1NMT2SIRT6SIRT1FOLH1 | |
| SCHEMBL18823863 | 0.83 | MMP1 (0.48) | MMP1MMP3MMP9 | |
| SCHEMBL20243562 | 0.82 | SIRT6 (0.44) | NMT1NMT2SIRT6SIRT1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11220523-B2 | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein | UNIVERSITÄT BASEL (CH) | 2022-01-11 | — | — | US | disclosed |
| US-20210061838-A1 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | UNIVERSITAET BASEL (CH) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11220523-B2 | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein | MAG, PMP22, SIGLEC7 | NMT1 611/4885NMT2 934/4885SIRT6 3792/4885 |
| US-20210061838-A1 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | MAG, PMP22, SIGLEC7 | NMT1 611/4885NMT2 934/4885SIRT6 3792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.